Artificial blood.
Blood substitutes are under development for transfusion in place of donor blood during emergencies and lengthy surgeries. The first generation of blood substitutes is currently in clinical trials.
Squires
Jerry E
JE
American Red Cross Biomedical Services, Arlington, VA 22307, USA. squiresj@usa.redcross.org
D000818:Animals; D001782:Blood Donors; D001802:Blood Substitutes / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D017848:Blood-Borne Pathogens; D002417:Cattle; D002986:Clinical Trials as Topic; D004655:Emulsions; D005466:Fluorocarbons / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006454:Hemoglobins / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010108:Oxyhemoglobins / Q000737:chemistry / Q000378:metabolism; D010313:Partial Pressure; D012307:Risk Factors; D065227:Transfusion Reaction
D001802:Blood Substitutes; D004655:Emulsions; D005466:Fluorocarbons; D006454:Hemoglobins; D010108:Oxyhemoglobins; C037158:polyhemoglobin; D010100:Oxygen